Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Many people start with weekly treatments for several weeks and then transition to maintenance sessions
KW-6356 is a second-generation A2A antagonist which has shown positive results with regard to motor progression in early-stage PD, as assessed by changes in the MDS-UPDRS motor score from baseline until the end of follow-up, both in combination with levodopa (NCT03703570) and as monotherapy (NCT02939391, Table 2) (Chen et al
The authors and publishers assume no liability for the use or misuse of information presented in this educational document
J., Chutuape, M
You should contact a doctor or seek emergency care if you experience: Difficulty breathing or swallowing Significant facial or throat swelling Persistent or worsening injection-site reactions (such as increasing pain, pus, or red streaks) Severe, unusual, or unexpected symptoms after use Signs of systemic illness like extreme fatigue, jaundice (yellowing of the skin or eyes), or neurological changes, which could indicate severe copper imbalance
G., Carpeggiani, C., and Maseri, A
US$ 28.91
US$ 20.20
US$ 27.78
US$ 28.59
US$ 27.99
